Abstract
The management of de novo hepatitis B (HBV) infection in children after liver transplantation is not well defined. Because this infection may induce severe liver disease in the graft liver, an efficient antiviral therapy is desirable. Here, we describe the favorable viral outcome observed in a liver transplanted girl with de novo HBV infection following combination therapy with lamivudine and tenofovir.
Original language | English |
---|---|
Journal | Transplant Infectious Disease |
Volume | 15 |
Issue number | 2 |
DOIs | |
Publication status | Published - Apr 2013 |
Keywords
- Children
- Combined antiviral therapy
- de novo HBV infection
- Hepatitis B
- Lamivudine
- Liver transplantation
- Tenofovir
ASJC Scopus subject areas
- Transplantation
- Infectious Diseases